|
Gastrointestinal |
Nausea was reported in 7% of patients. Vomiting has occurred in about 1% of
patients. Dyspepsia, constipation, dry mouth, and abdominal discomfort have
each occurred in less than 1% of patients. Taste perversion has also been
reported |
|
General |
|
|
Cardiac |
Hypotension, cardiac failure, bronchospasm, interference with symptoms of
hypoglycemia, Pallor, flushing, bradycardia (heart rate less than 50 beats
per minute), chest pain, syncope, pulmonary edema and heart block |
|
Central Nervous System |
Dizziness has occurred in 3% of patients; somnolence in 3%; confusion,
headache, and agitation in about 2%; and fatigue in about 1% of patients.
Paresthesia, asthenia, depression, abnormal thinking, anxiety, anorexia, and
lightheadedness were reported in less than 1% of patients. Seizures were
also reported in less than 1% of patients |
|
Pulmonary |
Bronchospasm, wheezing, dyspnea, nasal congestion, rhonchi, and rales have
each been reported in less than 1% of patients. |
|
Dermatologic |
Infusion site reactions including inflammation and induration were reported
in about 8% of patients. Edema, erythema, skin discoloration, burning at the
infusion site, thrombophlebitis, and local skin necrosis from extravasation
have each occurred in less than 1% of patients. |
|
Other |
Urinary retention, speech disorder, abnormal vision, midscapular pain,
rigors, and fever |
|